Arpad Szallasi

Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade

P. Blumberg, A. Szallasi, József Lázár, 2009, Expert opinion on drug discovery.

Inhibition of [3H]resiniferatoxin binding to rat dorsal root ganglion membranes as a novel approach in evaluating compounds with capsaicin-like activity

Zoltan Szallasi, Peter M. Blumberg, Arpad Szallasi, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Vanilloid receptor loss in rat sensory ganglia associated with long term desensitization to resiniferatoxin

Peter M. Blumberg, P. Blumberg, A. Szallasi, 1992, Neuroscience Letters.

Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root anglion membranes

Peter M. Blumberg, P. Blumberg, A. Szallasi, 1990, Brain Research.

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

A. Szallasi, Arpad Szallasi, S. R. Eid, 2007, Nature Reviews Drug Discovery.

TRP channels and pain.

A. Szallasi, Arpad Szallasi, Daniel N Cortright, 2009, Current pharmaceutical design.